Stocksigma LogoStocksigma Logo

Manorama Industries Approves ₹75 Crore Capital Infusion Across Wholly-Owned Global Subsidiaries

Manorama Industries' board approved a total capital infusion of up to ₹75 Cr across six wholly-owned global subsidiaries to fund working capital and

Manorama Industries Approves ₹75 Crore Capital Infusion Across Wholly-Owned Global Subsidiaries

Manorama Industries Ltd · Change in Management · 05 Sept 2026, 1:55 am

Manorama Industries Approves ₹75 Crore Capital Infusion Across Wholly-Owned Global Subsidiaries Manorama Industries' board approved a total capital infusion of up to ₹75 Cr across six wholly-owned global subsidiaries to fund working capital and operational growth. Allocations include up to ₹20 Cr in Ghana, ₹15 Cr each in Burkina Faso and Brazil, ₹10 Cr each in Nigeria and Chad, and ₹5 Cr in UAE. Additionally, the board approved the appointment of Dr. Rohini Tiwari as Non-Executive Independent Director for five years from 4th Sep'26 to 3rd Sep'31, succeeding Mr. Mudit Kumar Singh whose tenure ended on 5th Sep'26.

Original exchange filing (PDF)

More announcements from Manorama Industries Ltd

All Manorama Industries Ltd announcements